These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 35927536)

  • 41. Association of TMPRSS2 Gene Polymorphisms with COVID-19 Severity and Mortality: a Case-Control Study with Computational Analyses.
    Rokni M; Heidari Nia M; Sarhadi M; Mirinejad S; Sargazi S; Moudi M; Saravani R; Rahdar S; Kargar M
    Appl Biochem Biotechnol; 2022 Aug; 194(8):3507-3526. PubMed ID: 35386063
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and Other Coronaviruses: A Genome-wide Comparative Annotation and Analysis.
    Tarique M; Ahmad S; Malik A; Ahmad I; Saeed M; Almatroudi A; Qadah T; Murad MA; Mashraqi M; Alam Q; Al-Saleh Y
    Mol Cell Biochem; 2021 May; 476(5):2203-2217. PubMed ID: 33564990
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of biological correlates associated with respiratory failure in COVID-19.
    Oh JH; Tannenbaum A; Deasy JO
    BMC Med Genomics; 2020 Dec; 13(1):186. PubMed ID: 33308225
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genomic analysis of severe COVID-19 considering or not asthma comorbidity: GWAS insights from the BQC19 cohort.
    Amri O; Madore AM; Boucher-Lafleur AM; Laprise C
    BMC Genomics; 2024 May; 25(1):482. PubMed ID: 38750426
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Systematic review of host genetic association with Covid-19 prognosis and susceptibility: What have we learned in 2020?
    Ferreira de Araújo JL; Menezes D; Saraiva-Duarte JM; de Lima Ferreira L; Santana de Aguiar R; Pedra de Souza R
    Rev Med Virol; 2022 Mar; 32(2):e2283. PubMed ID: 34338380
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Investigation of an outbreak of symptomatic SARS-CoV-2 VOC 202012/01-lineage B.1.1.7 infection in healthcare workers, Italy.
    Loconsole D; Sallustio A; Accogli M; Leaci A; Sanguedolce A; Parisi A; Chironna M
    Clin Microbiol Infect; 2021 Aug; 27(8):1174.e1-1174.e4. PubMed ID: 33984489
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Polymorphisms and mutations of ACE2 and TMPRSS2 genes are associated with COVID-19: a systematic review.
    Li J; Wang Y; Liu Y; Zhang Z; Zhai Y; Dai Y; Wu Z; Nie X; Du L
    Eur J Med Res; 2022 Feb; 27(1):26. PubMed ID: 35193695
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The association between interferon lambda 3 and 4 gene single-nucleotide polymorphisms and the recovery of COVID-19 patients.
    Rahimi P; Tarharoudi R; Rahimpour A; Mosayebi Amroabadi J; Ahmadi I; Anvari E; Siadat SD; Aghasadeghi M; Fateh A
    Virol J; 2021 Nov; 18(1):221. PubMed ID: 34775984
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MUC22, HLA-A, and HLA-DOB variants and COVID-19 in resilient super-agers from Brazil.
    Castelli EC; de Castro MV; Naslavsky MS; Scliar MO; Silva NSB; Pereira RN; Ciriaco VAO; Castro CFB; Mendes-Junior CT; Silveira ES; de Oliveira IM; Antonio EC; Vieira GF; Meyer D; Nunes K; Matos LRB; Silva MVR; Wang JYT; Esposito J; Cória VR; Magawa JY; Santos KS; Cunha-Neto E; Kalil J; Bortolin RH; Hirata MH; Dell'Aquila LP; Razuk-Filho A; Batista-Júnior PB; Duarte-Neto AN; Dolhnikoff M; Saldiva PHN; Passos-Bueno MR; Zatz M
    Front Immunol; 2022; 13():975918. PubMed ID: 36389712
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nosocomial Outbreak of SARS-CoV-2 in a "Non-COVID-19" Hospital Ward: Virus Genome Sequencing as a Key Tool to Understand Cryptic Transmission.
    Borges V; Isidro J; Macedo F; Neves J; Silva L; Paiva M; Barata J; Catarino J; Ciobanu L; Duarte S; Vieira L; Guiomar R; Gomes JP
    Viruses; 2021 Apr; 13(4):. PubMed ID: 33916205
    [TBL] [Abstract][Full Text] [Related]  

  • 52. SARS-CoV-2 genetic diversity and variants of concern in Saudi Arabia.
    Obeid DA; Alsanea MS; Alnemari RT; Al-Qahtani AA; Althawadi SI; Mutabagani MS; Almaghrabi RS; Alhadheq FM; Alahideb BM; Alhamlan FS
    J Infect Dev Ctries; 2021 Dec; 15(12):1782-1791. PubMed ID: 35044933
    [TBL] [Abstract][Full Text] [Related]  

  • 53. COVID-19 pandemic: Insights into genetic susceptibility to SARS-CoV-2 and host genes implications on virus spread, disease severity and outcomes.
    Dastar S; Gharesouran J; Mortazavi D; Hosseinzadeh H; Kian SJ; Taheri M; Ghafouri-Fard S; Jamali E; Rezazadeh M
    Hum Antibodies; 2022; 30(1):1-14. PubMed ID: 34864654
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ERAP1 and ERAP2 Enzymes: A Protective Shield for RAS against COVID-19?
    D'Amico S; Tempora P; Lucarini V; Melaiu O; Gaspari S; Algeri M; Fruci D
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567739
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Polymorphisms in ACE, ACE2, AGTR1 genes and severity of COVID-19 disease.
    Sabater Molina M; Nicolás Rocamora E; Bendicho AI; Vázquez EG; Zorio E; Rodriguez FD; Gil Ortuño C; Rodríguez AI; Sánchez-López AJ; Jara Rubio R; Moreno-Docón A; Marcos PJ; García Pavía P; Villa RB; Gimeno Blanes JR
    PLoS One; 2022; 17(2):e0263140. PubMed ID: 35120165
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genomic Characterization of SARS-CoV-2 Isolated from Patients with Distinct Disease Outcomes in Mexico.
    Boukadida C; Taboada B; Escalera-Zamudio M; Isa P; Ramírez-González JE; Vazquez-Perez JA; Muñoz-Medina JE; Grajales-Muñiz C; González-Torres C; Gaytán-Cervantes FJ; Rincón-Rubio A; Matías-Florentino M; Esteban Paz-Juárez H; Sanchez-Flores A; Mendieta-Condado E; Barrera-Badillo G; Hernández-Rivas L; López S; López-Martínez I; Ávila-Ríos S; Arias CF
    Microbiol Spectr; 2022 Feb; 10(1):e0124921. PubMed ID: 35019701
    [TBL] [Abstract][Full Text] [Related]  

  • 57. SARS-CoV-2 reinfection and COVID-19 severity.
    Nguyen NN; Houhamdi L; Hoang VT; Delerce J; Delorme L; Colson P; Brouqui P; Fournier PE; Raoult D; Gautret P
    Emerg Microbes Infect; 2022 Dec; 11(1):894-901. PubMed ID: 35264078
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetic risk factors and COVID-19 severity in Brazil: results from BRACOVID study.
    Pereira AC; Bes TM; Velho M; Marques E; Jannes CE; Valino KR; Dinardo CL; Costa SF; Duarte AJS; Santos AR; Mitne-Neto M; Medina-Pestana J; Krieger JE
    Hum Mol Genet; 2022 Sep; 31(18):3021-3031. PubMed ID: 35368071
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human Genomics of COVID-19 Pneumonia: Contributions of Rare and Common Variants.
    Cobat A; Zhang Q; ; Abel L; Casanova JL; Fellay J
    Annu Rev Biomed Data Sci; 2023 Aug; 6():465-486. PubMed ID: 37196358
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dataset of single nucleotide polymorphisms of immune-associated genes in patients with SARS-CoV-2 infection.
    Katsaouni N; Llavona P; Khodamoradi Y; Otto AK; Körber S; Geisen C; Seidl C; Vehreschild MJGT; Ciesek S; Ackermann J; Koch I; Schulz MH; Krause DS
    PLoS One; 2023; 18(11):e0287725. PubMed ID: 37971979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.